Editorial Team

Editorial Staff

Assistant Editorial Director
Danielle Sposato
dsposato@hmpglobal.com

Managing Editor
Juliet Gallagher
jgallagher@hmpglobal.com

Associate Editor
Hannah Musick
hmusick@hmpglobal.com

Associate Editor
Grace Taylor
gtaylor@hmpglobal.com

Business Staff

President, HMP Omnimedia
Jeff Hennessy, Jr
jhennessyjr@hmpglobal.com

VP, Sales
Tony Deimler
tdeimler@hmpglobal.com

VP, Oncology Market Access
Sara Stewart
sstewart@hmpglobal.com

National Accounts Manager
Paige Koba
pkoba@hmpglobal.com

Classified Account Executive
Laura Chapas
lchapas@hmpglobal.com

Senior Circulation Manager
Bonnie Shannon
bshannon@hmpglobal.com

HMP

President
Dave DePinho

Executive Vice President, Trade Shows & Conferences
Bill Norton

Senior Creative Director
Vic Geanopulos

Graphic Designer
Lara Andrea Taber

Print Production Director
Andrea Steiger

Senior Manager, Audience Development
Bill Malriat

Chairman and Chief Executive Officer
Jeff Hennessy

Chief Financial Officer
Greg Salter

Executive Vice President of Operations
Anthony Mancini

Vice President of Finance, Controller
Meredith Cymbor-Jones

Executive Vice President, Marketing & Public Relations
Kelly Koczak McCurdy

AVP, Information Technology
Tim Shaw

Current Issue

February 2025

Volume 11

Issue 1

Current Issue

Issue Archive

Special Reports

Special Report

Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer

02/19/2025

Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD

The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.

The Predictable Cost of Care...

02/19/2025

Journal of Clinical Pathways

Sponsored

Special Report

2024 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Update: Impact on NSCLC Landscape

11/15/2024

The updated 2024 NCCN Guidelines® recommend broad genomic testing and the need for multidisciplinary care to accurately diagnose and treat non-small cell lung cancer. View this special report to learn more.

The updated 2024 NCCN...

11/15/2024

Journal of Clinical Pathways

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Team

Editorial Staff

Business Staff

HMP

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products